Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

BCPC · NASDAQ

Balchem Corp

$177.00 +154.90 (+694.00%)

Company overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients to the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates.

Sector
Basic Materials
Industry
Chemicals - Specialty
Exchange
NASDAQ
Market cap
$5.6B
Employees
1,372
Headquarters
Montvale, NJ
CEO
Theodore L. Harris
Listed
June 3, 1986
P/E
36.12
Dividend yield
0.61%

Company financials

Revenue
$1.1B
Gross profit
$384M
Operating income
$222M
EBITDA
$272M
Net income
$158M
EPS
$4.90
Total assets
$1.7B
Total debt
$185M
Gross margin
36.27%
Net margin
14.95%
Earnings yield
2.77%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

15.5959.05102.51145.97189.43
BCPC 1D NASDAQ O173.09H177.45L173.09C177.22+154.90 (+694.00%)Vol111.76K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
BCPC Stock news Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold Seeking Alpha
BCPC Stock news Balchem: 3 Key Takeaways for Long-Term Investors The Motley Fool
BCPC Stock news Balchem Corporation (BCPC) Q3 2026 Earnings Call Transcript Seeking Alpha
BCPC Press release Balchem Corporation Reports Third Quarter 2026 Financial Results GlobeNewswire
BCPC Press release Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026 GlobeNewswire
BCPC Press release Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026 GlobeNewsWire
BCPC Press release Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026 GlobeNewsWire
BCPC Stock news Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript Seeking Alpha
BCPC Press release Balchem Corporation Reports First Quarter 2026 Financial Results GlobeNewsWire
BCPC Stock news Sherwin-Williams (SHW) Beats Q1 Earnings and Revenue Estimates Zacks Investment Research
BCPC Stock news Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings Seeking Alpha
BCPC Press release Balchem Corporation Releases 2025 Sustainability Report GlobeNewsWire
BCPC Stock news Balchem: An Attractive Valuation Makes This Stock A Buy Seeking Alpha
BCPC Press release Balchem Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform to Deliver Research-Driven Nutrient Recommendations for Specialty Crops GlobeNewsWire
BCPC Stock news Balchem Stock Lands New $18 Million Investor as Firm Delivers Record $1 Billion in Sales The Motley Fool
BCPC Press release Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026 GlobeNewsWire
BCPC Press release Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026 GlobeNewsWire
BCPC Stock news Balchem Corporation (BCPC) Q4 2025 Earnings Call Transcript Seeking Alpha
BCPC Stock news First Look: Amazon tops Walmart; WBD--Netflix saga; oil up GuruFocus
BCPC Press release Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewsWire
FAQ

Questions about Balchem Corp

What does Balchem Corp do?
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients to the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates.
What is BCPC's market cap?
Balchem Corp (BCPC) is a listed stock with a live quote. The latest market cap on this page is $5.6B.
Where is Balchem Corp headquartered?
Balchem Corp is headquartered in Montvale, NJ.
How do I get BCPC news from the API?
Call GET /v1/news?tickers=BCPC. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does BCPC news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for BCPC, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the BCPC price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.